Author:
Soth Michael,Abbot Sarah,Abubakari Allassan,Arora Nidhi,Arzeno Humberto,Billedeau Roland,Dewdney Nolan,Durkin Kieran,Frauchiger Sandra,Ghate Manjiri,Goldstein David M.,Hill Ronald J.,Kuglstatter Andreas,Li Fujun,Loe Brad,McCaleb Kristen,McIntosh Joel,Papp Eva,Park Jaehyeon,Stahl Martin,Sung Man-Ling,Suttman Rebecca,Swinney David C.,Weller Paul,Wong Brian,Zecic Hasim,Gabriel Tobias
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference22 articles.
1. The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
2. Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development
3. p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis
4. Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders
5. Genovese, M. C.; Gao, L.; Yin, J.; Smith, S.; Weinblatt, M.; Smolen, J.; Wang, X.; Schieven, G.; Garcia-Meijide, J. A.; Latek, R.; Pasternak, R.; Kaul, S.; Roy, A.; Raymond, R., Thienel, U.; Wang, J. Presented at the American College of Rheumatology Scientific Meeting; Atlanta, GA, 2010; Poster 1119.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties;Bioorganic Chemistry;2023-06
2. Some novel peptides containing a modified pyrazolopyrimidine moiety: design, synthesis, and in vitro antibacterial screening;Applied Biological Chemistry;2023-04-21
3. Pyrazolo[3,4‐
d
]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities;Archiv der Pharmazie;2022-10-03
4. Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms;Arabian Journal of Chemistry;2022-05
5. Current status and future prospects of p38α/MAPK14 kinase and its inhibitors;European Journal of Medicinal Chemistry;2021-03